A Systematic Review and Meta-Analysis of Endocrine-Related Adverse Events Associated with Immune Checkpoint

Jeroen de Filette1, Corina Emilia Andreescu1, Filip Cools2

  • 1Department of Endocrinology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|March 13, 2019
PubMed

Insights

Immune checkpoint inhibitors (ICIs) like CTLA-4, PD-1, and PD-L1 can cause endocrine issues. This meta-analysis reveals a high incidence of these adverse events, especially with combination therapies.

Area of Science:

  • Oncology
  • Immunology
  • Endocrinology

Background:

  • Immune checkpoint inhibitors (ICIs) targeting CTLA-4, PD-1, or PD-L1 are standard treatments for advanced cancers.
  • The incidence of endocrine adverse events from ICIs is not fully characterized, particularly from real-world data.
  • Randomized controlled trials have limitations in capturing the full spectrum of ICI-induced endocrine toxicities.

Purpose of the Study:

  • To systematically review and meta-analyze the incidence of endocrine adverse events associated with immune checkpoint inhibitors.
  • To compare the risk of endocrine toxicities among different ICI agents (ipilimumab, nivolumab, pembrolizumab) and combination therapies.
  • To provide a comprehensive overview of ICI-induced hypophysitis, thyroid dysfunction, adrenal insufficiency, and diabetes mellitus.

Main Methods:

  • A systematic literature search of PubMed was conducted up to August 22nd, 2017.
  • Included studies comprised early phase I/II, phase III trials, and observational studies (prospective and retrospective).
  • Weighted incidence and risk ratios for specific endocrine adverse events were estimated across 101 studies involving 19,922 patients.

Main Results:

  • Hypophysitis incidence was higher with ipilimumab (5.6%) compared to nivolumab (0.5%) and pembrolizumab (1.1%).
  • PD-1/PD-L1 inhibitors showed a higher incidence of hypothyroidism (8.0-8.5%) than ipilimumab (3.8%).
  • Combination ICI therapy significantly increased the incidence of hypothyroidism (10.2-16.4%), hyperthyroidism (9.4-10.4%), hypophysitis (8.8-10.5%), and adrenal insufficiency (5.2-7.6%).

Conclusions:

  • Single-agent checkpoint blockade therapy is associated with a substantial incidence of endocrine adverse events.
  • Combination ICI therapy further elevates the risk and incidence of these endocrine toxicities.
  • Awareness and monitoring for endocrine adverse events are crucial in patients receiving ICI therapy.

Related Concept Videos

Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.0K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.8K
What is the Endocrine System?00:46

What is the Endocrine System?

The endocrine system sends hormones—chemical signals—through the bloodstream to target cells—the cells the hormones selectively affect. These signals are produced in endocrine cells, secreted into the extracellular fluid, and then diffuse into the blood. Eventually, they diffuse out of the blood and bind to target cells which have specialized receptors to recognize the hormones.
420.3K
The Endocrine System01:29

The Endocrine System

The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that...
1.3K
An Overview of the Endocrine System01:10

An Overview of the Endocrine System

The endocrine system, a complex network of glands, orchestrates physiological balance within the body through the production and secretion of hormones. These hormones are chemical messengers in intercellular communication, acting as conduits between the secretory cells and distant target sites. They traverse the circulatory system by being released into the extracellular fluid, and their impact is specific to cells possessing receptors for a particular hormone.
The endocrine system collaborates...
13.9K
Structures of the Endocrine System00:59

Structures of the Endocrine System

The intricate framework of the endocrine system encompasses a diverse array of glands, with their target tissues and organs strategically distributed throughout the body. Central to this network are the endocrine glands, specialized structures that lack ducts and release hormones directly into the interstitial fluid. Notably, the hypothalamus, a vital neuroendocrine organ situated in the brain, governs neural functions and serves as a potent source of hormonal regulation. Near the hypothalamus...
12.0K